QuidelOrtho insider Widder exercises options and sells 4,026 shares

Rhea-AI Filing Summary

QuidelOrtho Corp (QDEL)11/25/2025, he exercised 7,021 non-qualified stock options at an exercise price of $15.74 per share, receiving the same number of common shares. On the same date, he sold 4,026 shares of common stock at a weighted average price of $27.8106 per share, with individual sale prices ranging from $27.81 to $27.83. Following these transactions, he directly beneficially owned 37,061 shares of QuidelOrtho common stock.

11/25/2025 - 04:16 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

WIDDER KENNETH J

(Last) (First) (Middle)

9975 SUMMERS RIDGE ROAD

(Street)

SAN DIEGO CA 92121

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
QuidelOrtho Corp [ QDEL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/25/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/25/2025		M		7,021	A	$15.74	41,087	D
Common Stock	11/25/2025		S		4,026	D	$27.8106(1)	37,061	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Options	$15.74	11/25/2025		M			7,021	(2)	05/17/2026	Common Stock	7,021	$0	0	D

Explanation of Responses:

1. The weighted average sale price for these transactions was $27.8106 per share, with a range of $27.81 to $27.83. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.

2. Vested in full.

Remarks:

	/s/ Phillip S. Askim, attorney-in-fact for Kenneth J. Widder	11/25/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did QuidelOrtho (QDEL) report for Kenneth J. Widder?

QuidelOrtho reported that director Kenneth J. Widder exercised 7,021 non-qualified stock options and sold 4,026 shares of common stock on 11/25/2025.

At what price were Kenneth J. Widder’s QuidelOrtho (QDEL) stock options exercised?

The 7,021 non-qualified stock options were exercised at an exercise price of $15.74 per share.

What was the sale price of the QuidelOrtho (QDEL) shares sold by Kenneth J. Widder?

The 4,026 shares of QuidelOrtho common stock were sold at a weighted average price of $27.8106 per share, with a range of $27.81 to $27.83.

How many QuidelOrtho (QDEL) shares does Kenneth J. Widder own after the reported transactions?

After the reported option exercise and share sale, Kenneth J. Widder directly beneficially owned 37,061 shares of QuidelOrtho common stock.

What type of derivative security did Kenneth J. Widder hold in QuidelOrtho (QDEL)?

He held non-qualified stock options to purchase QuidelOrtho common stock at an exercise price of $15.74 per share, covering 7,021 shares.

What does the Form 4 for QuidelOrtho (QDEL) say about the pricing of the reported stock sale?

The filing states that the weighted average sale price was $27.8106 per share, with individual sales executed between $27.81 and $27.83 per share.